Search

Displaying results 9421 - 9430 of 9431 in total
  1. Drug

    Dasiprotimut-T

    go.drugbank.com/drugs/DB17287
    Experimental

    Dasiprotimut-T is a personalized therapeutic vaccine against B-cell lymphomas.[A254701] It has been investigated in clinical trials.

    Categories: dasiprotimut-TSynonyms: Dasiprotimut-T, Autologous lymphoma-derived immunoglobulin idiotype antigen vaccine conjugated to keyhole limpet hemocyanin
  2. Drug

    LuLym-T

    go.drugbank.com/drugs/DB17405
    Experimental

    LuLym-T is an investigational autologous immune cell therapy consisting of activated T Lymphocytes. Developed by Lukas Biomedical, Inc., it is currently being investigated in hepatocellular carcinoma.

    Synonyms: LuLym-T, Autologous Activated T Lymphocytes (ATL)
  3. Drug

    UCART22

    go.drugbank.com/drugs/DB17466
    Investigational

    UCART22 are allogeneic CD22-specific universal CAR-expressing T lymphocytes.

    Synonyms: Allogeneic gene-edited CAR T cells UCART22, Allogeneic TALEN gene-edited CAR T-Cells UCART22
  4. Drug

    AEM-28-14

    go.drugbank.com/drugs/DB17643
    Experimental

    AEM-28-14 is an analog of [AEM-28], an apolipoprotein E mimetic peptide, with a 400 percent greater cholesterol-lowering efficacy and a several-fold increase in drug tolerability.

  5. Drug

    Cerdulatinib

    go.drugbank.com/drugs/DB15499
    Investigational

    Cerdulatinib is under investigation in clinical trial NCT04021082 (CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/refractory Peripheral T-cell Lymphoma (PTCL)).

  6. Drug

    CS1 CAR-T

    go.drugbank.com/drugs/DB33915
    Experimental

    CS1 CAR-T is a biologic drug. CS1 CAR-T is under investigation in clinical trial NCT07809594 (CS1-Targeted CAR-T Cells for Relapsed/Refractory Multiple Myeloma).

    Synonyms: CS1 CAR-T
  7. Drug

    177Lu-PSMA-I&T

    go.drugbank.com/drugs/DB22176
    Investigational

    177Lu-PSMA-I&T is under investigation in clinical trial NCT04886986 (Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancer).

    Synonyms: 177Lu-PSMA I&T, 177Lu-PSMA-I&T
  8. Drug

    CTA30X UCAR-T

    go.drugbank.com/drugs/DB24819
    Investigational

    CTA30X UCAR-T is a biologic drug. CTA30X UCAR-T is under investigation in clinical trial NCT05015972 (UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies).

    Synonyms: CTA30X UCAR-T
  9. Drug

    Hops

    go.drugbank.com/drugs/DB10687
    Approved

    Hops allergenic extract is used in allergenic testing.

    Mixtures: VALERIANA E LUPPOLO DISPERT, VALERIANA E LUPPOLO DISPERT
  10. Drug

    Silicon

    go.drugbank.com/drugs/DB12982
    Approved

    Silicon is under investigation in clinical trial NCT00103246 (Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides).

    Mixtures: Advanced B & T Formula